Thierry Sornasse

2.4k total citations
30 papers, 1.4k citations indexed

About

Thierry Sornasse is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, Thierry Sornasse has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Rheumatology and 7 papers in Oncology. Recurrent topics in Thierry Sornasse's work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (8 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Thierry Sornasse is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (8 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Thierry Sornasse collaborates with scholars based in United States, United Kingdom and Belgium. Thierry Sornasse's co-authors include Hans Yssel, J E de Vries, Oberdan Léo, Jacques Urbain, Françoise Tielemans, Muriel Moser, Benjamin G. Cocks, Alessandra Zingoni, Lewis L. Lanier and Yuetsu Tanaka and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Thierry Sornasse

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Sornasse United States 12 1.1k 254 210 164 119 30 1.4k
Baishakhi Mahapatra India 3 905 0.9× 267 1.1× 164 0.8× 160 1.0× 113 0.9× 8 1.3k
Anne-Marie Rousseau Canada 5 780 0.7× 252 1.0× 128 0.6× 143 0.9× 134 1.1× 5 1.0k
Danielle L. Drayton United States 7 1.2k 1.2× 383 1.5× 195 0.9× 70 0.4× 123 1.0× 7 1.6k
Mahmoud Goodarzi United States 7 904 0.9× 307 1.2× 151 0.7× 119 0.7× 139 1.2× 11 1.3k
E Grau Garcia France 2 969 0.9× 344 1.4× 195 0.9× 229 1.4× 116 1.0× 2 1.4k
Mindi Walker United States 15 1.5k 1.4× 316 1.2× 138 0.7× 82 0.5× 112 0.9× 25 1.8k
Nikole Perdue United States 14 1.6k 1.5× 279 1.1× 218 1.0× 47 0.3× 117 1.0× 22 2.0k
Nobuaki Kawamura Japan 19 1.2k 1.1× 293 1.2× 363 1.7× 123 0.8× 327 2.7× 51 1.9k
Piotr Kuśnierczyk Poland 22 1.1k 1.0× 127 0.5× 158 0.8× 67 0.4× 63 0.5× 93 1.4k
Wendy Waegell United States 13 539 0.5× 219 0.9× 444 2.1× 178 1.1× 144 1.2× 16 1.3k

Countries citing papers authored by Thierry Sornasse

Since Specialization
Citations

This map shows the geographic impact of Thierry Sornasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Sornasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Sornasse more than expected).

Fields of papers citing papers by Thierry Sornasse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Sornasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Sornasse. The network helps show where Thierry Sornasse may publish in the future.

Co-authorship network of co-authors of Thierry Sornasse

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Sornasse. A scholar is included among the top collaborators of Thierry Sornasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Sornasse. Thierry Sornasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravishankar, B, Preeti Lal, Thierry Sornasse, et al.. (2023). POS1545 MODULATION OF SERUM BIOMARKERS IN PATIENTS WITH PSA TREATED WITH RISANKIZUMAB IN THE PHASE 3 KEEPSAKE 2 STUDY. 1141–1142. 1 indexed citations
6.
Sornasse, Thierry, In Ho Song, Timothy R. D. J. Radstake, & Iain B. McInnes. (2020). FRI0026 PROTEOMICS ANALYSIS COMPARING THE MODE OF ACTION OF UPADACITINIB AND ADALIMUMAB HEAD TO HEAD IN RA IDENTIFIES NOVEL, DISCRETE EARLY IMMUNE PATHWAY MODULATION IN THE SELECT-COMPARE PHASE 3 STUDY. Annals of the Rheumatic Diseases. 79. 585–586. 3 indexed citations
8.
Tuckwell, Katie, Cem Gabay, Thierry Sornasse, et al.. (2019). Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab. Advances in Rheumatology. 59(1). 54–54. 10 indexed citations
9.
Charles‐Schoeman, Christina, Thierry Sornasse, & Jeremy Sokolove. (2019). THU0166 TREATMENT WITH UPADACITINIB IS ASSOCIATED WITH IMPROVEMENTS IN REVERSE CHOLESTEROL TRANSPORT IN PATIENTS WITH RHEUMATOID ARTHRITIS: CORRELATION WITH CHANGES IN INFLAMMATION AND HDL LEVELS. Annals of the Rheumatic Diseases. 78. 356–357. 4 indexed citations
10.
Haddon, D. James, Thierry Sornasse, Michael J. Townsend, Jinglan Pei, & Margaret Michalska. (2019). AB0272 EVALUATION OF CXCL13, SICAM-1, MMP-3 AND S100A8/A9 AS SERUM BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB. Annals of the Rheumatic Diseases. 78. 1593–1594. 1 indexed citations
11.
Denton, Christopher P., Voon H Ong, Shiwen Xu, et al.. (2018). Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. Annals of the Rheumatic Diseases. 77(9). 1362–1371. 125 indexed citations
12.
Stifano, Giuseppina, Thierry Sornasse, Lisa Rice, et al.. (2018). Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology. 70(6). 912–919. 43 indexed citations
13.
Zingoni, Alessandra, Thierry Sornasse, Benjamin G. Cocks, et al.. (2004). NK cell regulation of T cell-mediated responses. Molecular Immunology. 42(4). 451–454. 72 indexed citations
14.
Sornasse, Thierry, et al.. (1997). Induction of human T helper cell type 1 differentiation results in loss of IFN-γ receptor β-chain expression. The Journal of Immunology. 158(12). 5627–5631. 38 indexed citations
15.
Sornasse, Thierry, et al.. (1996). Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level.. The Journal of Experimental Medicine. 184(2). 473–483. 226 indexed citations
16.
Vries, J E de, et al.. (1995). Antagonizing the differentiation and functions of human T helper type 2 cells. Current Opinion in Immunology. 7(6). 771–778. 23 indexed citations
17.
Moser, Muriel, Thibaut De Smedt, Thierry Sornasse, et al.. (1995). Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo. European Journal of Immunology. 25(10). 2818–2824. 188 indexed citations
18.
Flamand, Véronique, Thierry Sornasse, Kris Thielemans, et al.. (1994). Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. European Journal of Immunology. 24(3). 605–610. 265 indexed citations
19.
Becker, Geneviève De, Thierry Sornasse, Nasrin Nabavi, et al.. (1994). Immunoglobulin isotype regulation by antigen‐presenting cells in vivo. European Journal of Immunology. 24(7). 1523–1528. 45 indexed citations
20.
Sornasse, Thierry, Véronique Flamand, Geneviève De Becker, et al.. (1993). Loading of Dendritic Cells with Antigen in Vitro Or in Vivo by Immunotargeting can Replace the Need for Adjuvant. Advances in experimental medicine and biology. 329. 299–303. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026